Cargando…
Targeted lung denervation for moderate to severe COPD: a pilot study
BACKGROUND: Parasympathetic pulmonary nerves release acetylcholine that induces smooth muscle constriction. Disruption of parasympathetic pulmonary nerves improves lung function and COPD symptoms. AIMS: To evaluate ‘targeted lung denervation’ (TLD), a novel bronchoscopic therapy based on ablation of...
Autores principales: | Slebos, Dirk-Jan, Klooster, Karin, Koegelenberg, Coenraad F N, Theron, Johan, Styen, Dorothy, Valipour, Arschang, Mayse, Martin, Bolliger, Chris T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4413833/ https://www.ncbi.nlm.nih.gov/pubmed/25739911 http://dx.doi.org/10.1136/thoraxjnl-2014-206146 |
Ejemplares similares
-
Endobronchial valves for emphysema: an individual patient-level reanalysis of randomised controlled trials
por: Klooster, Karin, et al.
Publicado: (2017) -
Lung volume reduction coil treatment for patients with severe emphysema: a European multicentre trial
por: Deslee, Gaëtan, et al.
Publicado: (2014) -
Necessity of amoxicillin clavulanic acid in addition to prednisolone in mild-to-moderate COPD exacerbations
por: Brusse-Keizer, Marjolein, et al.
Publicado: (2014) -
Serum biomarkers and outcomes in patients with moderate COPD: a substudy of the randomised SUMMIT trial
por: Celli, Bartolome R, et al.
Publicado: (2019) -
Effect of aclidinium bromide on cough and sputum symptoms in moderate-to-severe COPD in three phase III trials
por: McGarvey, Lorcan, et al.
Publicado: (2016)